We are live on ! Find out more
GP

Geneva Partners Portfolio holdings

AUM $208M
1-Year Est. Return 72.91%
This Fund
S&P 500
This Quarter Est. Return
+15.01%
1 Year Est. Return
+72.91%
3 Year Est. Return
+251.81%
5 Year Est. Return
+429.32%
10 Year Est. Return
AUM
$153M
AUM Growth
+$36.4M
Cap. Flow
+$28.4M
Cap. Flow %
18.5%
Top 10 Hldgs %
38.35%
Holding
86
New
26
Increased
24
Reduced
19
Closed
13

Top Buys

Rank Stock Value
1
UBER icon
Uber
UBER
+$5.09M
2
NVDA icon
NVIDIA
NVDA
+$4.78M
3
LVS icon
Las Vegas Sands
LVS
+$3.12M
4
PANW icon
Palo Alto Networks
PANW
+$2.91M
5
GLD icon
SPDR Gold Trust
GLD
+$2.66M

Top Sells

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$3.65M
2
AMGN icon
Amgen
AMGN
+$2.64M
3
PM icon
Philip Morris
PM
+$2.55M
4
ELV icon
Elevance Health
ELV
+$2.44M
5
WMB icon
Williams Companies
WMB
+$1.96M

Sector Composition

Rank Sector Weight
1 Technology 29.59%
2 Industrials 16.97%
3 Healthcare 12.36%
4 Consumer Staples 8.87%
5 Consumer Discretionary 5.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNST icon
26
Monster Beverage
MNST
$95.1B
$2.18M 1.42%
37,897
-1,525
-4% -$86.7K
CMG icon
27
Chipotle Mexican Grill
CMG
$43.9B
$2.15M 1.4%
+50,200
New +$1.99M
CELH icon
28
Celsius Holdings
CELH
$7.38B
$2.06M 1.35%
+41,505
New +$1.65M
AZN icon
29
AstraZeneca
AZN
$269B
$1.91M 1.25%
13,350
+4,985
+60% +$733K
CMI icon
30
Cummins
CMI
$83.6B
$1.83M 1.2%
7,474
-2,637
-26% -$597K
SPY icon
31
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$1.75M 1.14%
3,955
+10
+0.3% +$4.2K
MDB icon
32
MongoDB
MDB
$25.8B
$1.5M 0.98%
+3,648
New +$1.06M
TMO icon
33
Thermo Fisher Scientific
TMO
$214B
$1.46M 0.95%
2,792
-100
-3% -$54K
RSG icon
34
Republic Services
RSG
$67.4B
$1.41M 0.92%
9,176
-3,525
-28% -$504K
MCK icon
35
McKesson
MCK
$104B
$1.39M 0.91%
+3,263
New +$1.25M
MPLX icon
36
MPLX
MPLX
$58.6B
$1.36M 0.89%
40,000
RMBS icon
37
Rambus
RMBS
$8.95B
$1.25M 0.82%
+19,550
New +$1.08M
ABT icon
38
Abbott
ABT
$188B
$1.24M 0.81%
11,381
-100
-0.9% -$10.7K
ORCL icon
39
Oracle
ORCL
$339B
$1.1M 0.72%
+9,230
New +$954K
EPD icon
40
Enterprise Products Partners
EPD
$83.7B
$1.05M 0.69%
40,000
MCD icon
41
McDonald's
MCD
$193B
$995K 0.65%
3,335
-90
-3% -$26.1K
LRCX icon
42
Lam Research
LRCX
$316B
$848K 0.55%
+13,190
New +$743K
XNTK icon
43
State Street SPDR NYSE Technology ETF
XNTK
$1.94B
$844K 0.55%
6,052
+3,679
+155% +$462K
TSM icon
44
TSMC
TSM
$1.94T
$712K 0.46%
+7,055
New +$657K
XOM icon
45
ExxonMobil
XOM
$650B
$697K 0.46%
6,503
-824
-11% -$89.9K
WMB icon
46
Williams Companies
WMB
$85.8B
$692K 0.45%
21,199
-65,330
-76% -$1.96M
PHYS icon
47
Sprott Physical Gold
PHYS
$14.6B
$691K 0.45%
46,300
+13,000
+39% +$201K
OKE icon
48
Oneok
OKE
$56.7B
$686K 0.45%
11,117
-19,019
-63% -$1.18M
VYM icon
49
Vanguard High Dividend Yield ETF
VYM
$80.8B
$676K 0.44%
6,370
+2,256
+55% +$237K
TSLA icon
50
Tesla
TSLA
$1.18T
$673K 0.44%
+2,569
New +$514K

Similar funds

Geneva Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Geneva Partners held 86 positions worth $153M, up 31% from $117M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Geneva Partners deployed $28.4M of net new capital in Q2 2023, opening 26 new positions and adding to 24 existing holdings. Its largest new stake was Uber: 136,920 shares worth $5.91M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $2.64M trimmed.

  • Geneva Partners's largest Q2 2023 buy was Uber: 136,920 shares worth $5.91M.
  • Geneva Partners added most to Palo Alto Networks in Q2 2023, an estimated $2.91M increase.
  • Geneva Partners's biggest Q2 2023 reduction was Amgen, cutting an estimated $2.64M.
  • Geneva Partners fully exited Analog Devices in Q2 2023, selling an estimated $3.65M.
  • Geneva Partners's ten largest holdings make up 38% of its $153M portfolio in Q2 2023.
  • Geneva Partners opened 26 new positions and closed 13 in Q2 2023.
  • Geneva Partners's portfolio value rose 31% quarter-over-quarter to $153M.

Based on Geneva Partners's 13F filing for Q2 2023, filed 3 Aug 2023.